Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.8300
-0.0410 (-4.71%)
At close: Jul 22, 2025, 4:00 PM
0.8600
+0.0300 (3.61%)
After-hours: Jul 22, 2025, 7:56 PM EDT
Iterum Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover Iterum Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $7, which forecasts a 743.37% increase in the stock price over the next year. The lowest target is $5 and the highest is $9.
Price Target: $7 (+743.37%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 8, 2025.
Analyst Ratings
The average analyst rating for Iterum Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +984.34% | May 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +502.41% | Sep 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +502.41% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +622.89% | Jun 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +622.89% | May 31, 2024 |
Financial Forecast
Revenue This Year
4.76M
Revenue Next Year
17.62M
from 4.76M
Increased by 270.19%
EPS This Year
-0.38
from -1.26
EPS Next Year
-0.05
from -0.38
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.8M | 20.4M | 62.6M | ||
| Avg | 4.8M | 17.6M | 51.3M | ||
| Low | n/a | 14.8M | 40.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 329.1% | 255.1% | ||
| Avg | - | 270.2% | 191.3% | ||
| Low | - | 210.9% | 128.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.22 | 0.11 | 0.11 |
| Avg | -0.38 | -0.05 | 0.01 |
| Low | -0.53 | -0.19 | -0.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.